# Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM

> **NCT05405244** · PHASE3 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 55 (actual)

## Conditions studied

- Overweight and Obesity
- Eating Behavior

## Interventions

- **DRUG:** Placebo
- **DRUG:** Bromocriptine-QR

## Key facts

- **NCT ID:** NCT05405244
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-19
- **Primary completion:** 2019-09-19
- **Final completion:** 2019-09-19
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2022-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05405244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05405244, "Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05405244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*